PRESS RELEASES 1/15/2013 8:00:13 AM | Marketwire News

Advanomics Corporation, the Parent Company of Sunshine Biopharma, Files a New Patent Application for Its Multidrug Resistance Adva-27a Anticancer Compound

2013-01-15T13:00:13+00:00

For Additional Information Contact:

Camille Sebaaly

CFO

Sunshine Biopharma Inc.

Direct Line: 514-814-0464

camille.sebaaly@sunshinebiopharma.com


www.sunshinebiopharma.com


sky scraper bmp code here